have gestational diabetes mellitus (GDM), and the "2006 Multicenter Study on Screening for Gestational Diabetes Mellitus" estimated that the prevalence of GDM is 2.92% [1] . In 1999 the Japan Diabetes Society (JDS) diagnostic criteria for GDM required that two or more of the following conditions were met on a 75-gram oral glucose tolerance test (75-g OGTT): fasting blood glucose level ≥100 mg/dL (5.5 mmol/L); 1-hr plasma glucose ≥180 mg/dL (10.0 mmol/L); and 2-hr plasma glucose ≥150 mg/dL (8.3 mmol/L) [1] . We accepted the new diagnostic criteria proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) in March 2010 [2] and began to use these criteria in July 2010. Using the same database, we recalculated the prevalence of GDM as research Design and methods
Survey period and participating institutions
We studied Japanese women who presented at nine institutions from July 2007 through December 2008. In a cross-sectional study, we intended to screen 100 healthy women each in the following periods: nonpregnancy, during pregnancy (4n ± 2 weeks: n = 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) , and during the puerperium (1 month ± 1 week later). Before screening, we obtained the approval of the institutional review boards at the participating institutions.
Exclusion criteria
Women who met any of the following criteria were excluded from the study: a diagnosis of diabetes mellitus, hepatic disease, renal disease, or hematologic disease; BMI non-pregnancy <18.5 kg/m 2 ; BMI nonpregnancy ≥25 kg/m 2 ; blood pressure ≥140/90 mmHg (187/120 hPa); urinary protein positive (≥+); urinary glucose positive (≥+).
Examinations and measurements
We examined gestational age (weeks), height, weight (non-pregnancy, present weight), family history of diabetes mellitus, complications, blood pressure, urinary protein, urinary glucose, hemoglobin (Hb), hematocrit (Ht), HbA1c calibrated by CRM004, a reference material for HbA1c measurement certified by the JDS [7] , GA (enzymatic method; LUCICA GA-L, Asahi KASEI, Tokyo) [8] , albumin (BCG method), and casual plasma glucose level with the time elapsed since having a meal. HbA1c (%) was estimated as the NGSP equivalent value (%), calculated by the formula HbA1c (%) = HbA1c (JDS) (%) + 0.4%, considering the relational expression of HbA1c (JDS) (%) measured by the previous Japanese standard substance and measurement methods and HbA1c (NGSP) [9] .
For women who underwent a 75-g OGTT, the timing of the test and the plasma glucose and insulin levels were recorded. We used the classification of BMI recommended by the Japan Society for the Study of Obesity [10] . In the present study, we studied women who met the following criteria: casual plasma glucose level <126 mg/dL; 1-h postprandial plasma glucose level <180 mg/dL; 2-h postprandial plasma glucose level <150 mg/dL; postprandial plasma glucose level after more than three hours <126 mg/dL. In the women who underwent a 75-g OGTT, plasma gludefined by the new international diagnostic criteria [2] , and found that it has become 12.08%. More than 10 percent of pregnant women thus have hyperglycemic disorders, and diabetic pregnancy has become one of the most important complications in Japan.
The objectives of managing diabetic pregnancies are as follows: 1) prevention of perinatal complications in mothers and fetuses/infants; 2) prevention of the development of diabetes mellitus and metabolic syndrome from GDM; 3) Prevention of the development of diabetes mellitus and metabolic syndrome of the neonates in their future. To meet these objectives, universal screening for GDM, strict glycemic control during pregnancy, and rescreening reevaluation and close follow-up during the puerperium are of prime importance [3] . The report of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study Cooperative Research Group indicates strong, continuous associations of maternal glucose levels below the diabetic level with increased birth weight and increased cordblood serum C-peptide levels [4] .
During pregnancy, women with glucose intolerance are advised to control their blood glucose to achieve target levels before meals (≤100 mg/dL (5.5 mmol/L)) and 2 hours after meals (<120 mg/dL (6.7 mmol/L)). The most frequently used markers for glycemic control have been hemoglobin A1c (HbA1c) and self-monitored blood glucose levels measured seven times a day (before three meals, two hours after three meals, and before going to bed) [5] . HbA1c reflects changes in glycemic control status over the past one to two months. However, as pregnancy progresses, insulin resistance increases and glucose tolerance changes, and the period of pregnancy is limited (280 days). Therefore, stricter glycemic control than that in non-pregnant women is necessary to prevent perinatal complications. Markers that more precisely reflect variations in blood glucose levels during pregnancy are thus urgently needed. In contrast to HbA1c, glycated albumin (GA) reflects blood glucose profiles during a more recent period. GA is thus being increasingly used as a marker of blood glucose profiles for the past two to four weeks [6] . In the present multicenter study, we determined the reference intervals of GA and HbA1c during pregnancy and evaluated their potential for the management of impaired glucose tolerance in pregnant women. tics are summarized in Table 1 .
Profiles of blood glucose markers during pregnancy
The profiles of HbA1c, GA, and plasma glucose levels in healthy pregnant women are shown in Fig. 1 . As pregnancy progressed, HbA1c temporarily decreased in the second trimester, and subsequently increased to the level of non-pregnancy or that of the first trimester. GA gradually decreased as pregnancy progressed toward the third trimester, and GA levels were significantly lower than those during non-pregnancy in the second trimester onward. The plasma glucose level during pregnancy was lower than those during nonpregnancy and the puerperium. No marked variations were observed during pregnancy. Next, we studied changes in HbA1c levels and GA levels according to trimester. HbA1c levels were significantly lower in the second trimester than in the first trimester (4.9 ± 0.5 vs. 5.2 ± 0.5%, p<0.01) ( Table 2 ), but did not differ significantly between the third and the first trimesters (5.2 ± 0.6 vs. 5.2 ± 0.5%, N.S.) ( Table 2 ). On the other hand, GA levels in the second trimester (13.7 ± 1.9 vs. 14.4 ± 2.2%, p<0.01) and third trimester (13.3 ± 2.0 vs. 14.4 ± 2.2%, p<0.01) were significantly lower than those in the first trimester ( Table 2 ). The GA/HbA1c ratio was significantly low in the third trimester compared with the non-pregnancy (2.56 ± 0.43 vs. 2.71 ± 0.42%, p<0.01) ( Table 2 ). However, it did not differ significantly between the first trimester and non-pregcose levels that met all of the following criteria were assessed: fasting plasma glucose level <92 mg/dL, 1-h plasma glucose level <180 mg/dL; and 2-h plasma glucose level <153 mg/dL.
Analytical methods
We identified reference individuals using a method to exclude potentially abnormal laboratory results. We then used a parametric method to calculate the mean ± 2SD, and defined it as the reference interval during pregnancy. To test for statistical significance, we used the Mann-Whitney U-test. A p value of less than 0.05 was considered to indicate statistical significance (p<0.05). We also evaluated factors that were likely to influence HbA1c and GA levels during pregnancy. The Stat Flex computer program (for Windows; Artec, Osaka, Japan) was used for all statistical analyses. results
Subjects
Of the 1069 women recruited, 393 met the above exclusion criteria, and the remaining 676 were studied. The number of women in the first ten weeks of pregnancy was fewer than expected; pregnant women in this period were excluded mainly because of their BMI before pregnancy (225 ineligible patients). After the exclusion of non-pregnant women, 574 pregnant women were studied. Their background characteris- 
Factors influencing GA and HbA1c levels
We evaluated factors influencing GA and HbA1c levels in the healthy pregnant women. Data derived from women who tested positive for urinary glucose were compared with those from the control group (574 pregnant women who met the characteristics described in Table 1 ). The casual plasma glucose level (96.9 ± 60.9 vs. 84.8 ± 25.4 mg/dL, p<0.01), HbA1c level (5.3 ± 0.8 vs. 5.1 ± 0.6%, p<0.05), and GA level (14.1 ± 2.3 vs. 13.6 ± 2.1%, p<0.01) were significantly higher in women who were positive for urinary glucose than in the control group (Fig. 2) . In women with proteinuria, nancy (2.77 ± 0.44 vs. 2.71 ± 0.42%, N.S.). Likewise It did not differ significantly between the second trimester and non-pregnancy (2.78 ± 0.42 vs. 2.71 ± 0.42%, N.S.) ( Table 2 ).
Reference intervals of GA and HbA1c in healthy pregnant women
The reference intervals of GA and HbA1c throughout normal pregnancy were 11.5-15.7% and 4.5-5.7%, respectively ( Table 2 ). The reference intervals of GA and HbA1c throughout normal non-pregnancy were 12.0-16.2% and 4.8-5.6%, respectively. women (BMI ≥ 25 kg/m 2 ), the casual plasma glucose level (94.5 ± 36.7 vs. 84.8 ± 25.4 mg/dL, p<0.01) and HbA1c level (5.3 ± 0.7 vs. 5.0 ± 0.6%, p<0.01) were significantly higher and the GA level (13.2 ± 2.2 vs. 13.6 ± 2.1%, p<0.01) was significantly lower than the corresponding values in the control group (Fig. 2) . In women with lower Ht (<33%, n=133), HbA1c levels (5.1 ± 0.6 vs. 5.2 ± 0.6%, p<0.01) were significantly higher than those (Ht ≥33 to ≤38%, n=358). In women with higher Ht (>38%, n=83), GA levels (13.3 ± 2.2 vs. 13.6 ± 2.1%, p < 0.05) were lower than those (Ht ≥33 to ≤38%, n=358) (Fig. 3). the casual plasma glucose level (86.3 ± 33.6 vs. 84.8 ± 25.4 mg/dL, p < 0.05) and HbA1c levels (5.2 ± 0.5 vs. 5.1 ± 0.6%, p < 0.05) were significantly higher, and the GA level (12.9 ± 2.4 vs. 13.6 ± 2.1%, p < 0.01) was significantly lower than those in the control group (Fig. 2) . In lean women (BMI <18.5 kg/m 2 ), the casual plasma glucose level (86.5 ± 25.4 vs. 84.8 ± 25.4 mg/dL, N.S.) and HbA1c level (5.1 ± 0.6 vs. 5.1 ± 0.6%, N.S.) were not significantly higher than those in the control group (BMI ≥ 18.5 to < 25 kg/m 2 ). In contrast, GA levels (13.9 ± 2.3 vs. 13.6 ± 2.1%, p<0.01) were significantly higher than those in the control group (Fig. 2) . In obese * p<0.05, **p<0.01 vs. control group (574 pregnant women who met the characteristics described in Table 1 ) tors that influence GA levels. GA is known to decrease in patients with nephrotic syndrome [23] . Sufficient care should be taken, since GA levels may be lower in pregnant women with proteinuria. GA also is known to be influenced by BMI [24, 25] . BMI was also shown to influence GA in the present study, although its impact was minor. We conducted a multicenter study and proposed that the reference intervals of GA and HbA1c in healthy Japanese pregnant women were 11.5-15.7% and 4.5-5.7%, respectively. Glycemic control should be practiced more strictly than during non-pregnancy to reduce the risk of perinatal complications. For this purpose, GA should be used as marker during pregnancy, since GA reflects glycemic control status, rapidly as well as markedly. The development of an enzymatic method for measurement of GA in serum has facilitated the quantification of GA in multiple samples, performed with the use of a conventional automatic biochemical analyzer. Pre-treatment is not required, and GA analysis can be done with other biochemical tests. Reproducible results have been obtained. GA is thus a potentially useful marker in clinical settings. We are currently studying the usefulness of GA as a marker for glycemic control status in patients with diabetes mellitus and GDM.
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Other 
Discussion
Strict glycemic control is essential to prevent perinatal complications during pregnancy. Therefore, blood glucose levels need to be controlled more strictly during pregnancy than non-pregnancy. Because GA reflects the recent glycemic control status more sensitively than HbA1c [11] , it could be a useful marker for management in diabetic pregnant women [12] . More recently, an enzymatic method for GA measurement [8] has been developed for use in clinical settings. This method, which is characterized by high precision, can be easily used with an automatic biochemical analyzer at any institute. In the present multicenter study, we attempted to determine the reference intervals of GA and HbA1c levels throughout pregnancy in healthy Japanese pregnant women and obtained a GA reference interval of 11.5-15.7% and an HbA1c reference interval of 4.5-5.7%. Mosca et al reported that in the multi center studies the reference interval for HbA1c was 4.0-5.5% in Italian pregnant women and it was 4.8-6.2% in Italian non-pregnant women, respectively [13] . The reference intervals of GA and HbA1c in Japanese who expected pregnancy women with normal glucose tolerance range from 11% to 16%, and from 4.7% to 6.2%, respectively [14] .
During pregnancy, HbA1c decreased in the second trimester and increased in the third trimester. This profile of HbA1c levels was similar to that of Ht levels, which also decreased in the second trimester and increased in the third trimester because plasma components increased more markedly than blood cell components during the course of pregnancy, and physiological anemia (hydremia) subsequently developed. Phelps et al. reported the biphasic variation of HbA1c levels during pregnancy [15] , and Worth et al. conducted a longitudinal study [16] . Hashimoto et al. reported biphasic variations of HbA1c levels in Japanese subjects with normal glucose tolerance [17] and in Japanese pregnant women with diabetes mellitus [18] , and suggested the involvement of iron-deficiency anemia in this phenomenon. Further studies are needed to identify causative factors. However, we recommend measurement of GA as a marker for glycemic control status during pregnancy because GA is not affected by this phenomenon. In addition, HbA1c is known to increase as a result of extension of red cell survival due to iron-deficiency anemia [19] [20] [21] . Kim et al. conducted a large investigation that confirmed this finding [22] .
Urinary protein and BMI have been identified as fac-
